TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DE

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

13 янв 2025 00:00:00 Источник Nasdaq GlobeNewswire

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

10 янв 2025 07:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DE

26 дек 2024 09:39:11 Источник NetDania Notify

NetDania - New 12 months High: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DE

24 дек 2024 08:45:03 Источник NetDania Notify

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

23 дек 2024 15:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DE

23 дек 2024 15:04:36 Источник NetDania Notify

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

20 дек 2024 15:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DE

20 дек 2024 11:00:15 Источник NetDania Notify

NetDania - New 12 months High: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DE

18 дек 2024 09:01:35 Источник NetDania Notify

NetDania - New 12 months High: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DE

17 дек 2024 08:45:20 Источник NetDania Notify

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

17 дек 2024 06:30:00 Источник Nasdaq GlobeNewswire

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

11 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

05 дек 2024 17:00:00 Источник Nasdaq GlobeNewswire

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial

04 дек 2024 01:00:00 Источник Nasdaq GlobeNewswire

Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference

25 ноя 2024 17:00:00 Источник Nasdaq GlobeNewswire

Teva to Present at the Jefferies London Healthcare Conference

08 ноя 2024 15:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DE

06 ноя 2024 08:46:07 Источник NetDania Notify

Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

06 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

01 ноя 2024 14:05:00 Источник Nasdaq GlobeNewswire

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as Results of Real-World Analyses of UZEDY® (risperidone)

01 ноя 2024 14:00:00 Источник Nasdaq GlobeNewswire